Literature DB >> 7726717

A family study of manic-depressive (bipolar I) disease. Is it a distinct illness separable from primary unipolar depression?

G Winokur1, W Coryell, M Keller, J Endicott, A Leon.   

Abstract

OBJECTIVE: To determine whether bipolar I illness is autonomous or part of a multifactorial continuum with unipolar depression. In this study, we compare familial bipolar I illness and depression among three groups: probands with bipolar I disorder; probands with primary unipolar disorder; and controls. We also examine a continuum of severity between psychotic and nonpsychotic patients with bipolar I disorder. Considerable data suggest that bipolar I illness is distinct from unipolar illness as regards epidemiology, familial psychiatric illness, course, response to treatment, and biologic findings.
METHOD: Probands were separated into bipolar I and primary unipolar depressive groups. Personally interviewed family members of these patients were compared on variables of bipolar illness or schizoaffective mania and unipolar or schizoaffective depression. A personally examined control group was compared with the relatives of the two proband groups. Similar analyses were performed using data obtained by a systematic family history method. For the same familial variables, psychotic and nonpsychotic manic probands were compared.
RESULTS: Familial mania is more frequent in families of patients with bipolar disease than in controls or in families of patients with primary unipolar disorder. The latter two groups did not differ in amount of mania. Unipolar depressive illness or schizoaffective depression was higher in families of probands with bipolar and unipolar disorder than in controls. Probands with bipolar disease separated into those who had psychotic symptoms (including schizoaffective mania) and no psychotic symptoms did not differ from each other in risk for familial mania or depression.
CONCLUSIONS: Bipolar I illness is a separate illness from primary unipolar illness because of an increase in familial mania. Patients with primary unipolar disease and controls show the same amount of familial mania. Lack of an increase in familial illness according to the severity of bipolar disease is against an affective continuum.

Entities:  

Mesh:

Year:  1995        PMID: 7726717     DOI: 10.1001/archpsyc.1995.03950170041006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  14 in total

Review 1.  Review of bipolar molecular linkage and association studies.

Authors:  Wade Berrettini
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

Review 2.  Bipolar disorder and schizophrenia: convergent molecular data.

Authors:  Wade Berrettini
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

3.  Genetics of major mood disorders.

Authors:  Wade Berrettini
Journal:  Psychiatry (Edgmont)       Date:  2004-09

4.  Bipolar disorder and schizophrenia: not so distant relatives?

Authors:  Wade Berrettini
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

Review 5.  Genetics of bipolar disorder.

Authors:  N Craddock; I Jones
Journal:  J Med Genet       Date:  1999-08       Impact factor: 6.318

6.  Burden of illness in bipolar depression.

Authors:  J Sloan Manning
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

7.  A study of familial aggregation of depression, dementia and Parkinson's disease.

Authors:  S Fahim; C M van Duijn; F M Baker; L Launer; M M Breteler; W J Schudel; A Hofman
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082

Review 8.  The relationship of major depressive disorder to bipolar disorder: continuous or discontinuous?

Authors:  Franco Benazzi
Journal:  Curr Psychiatry Rep       Date:  2005-12       Impact factor: 8.081

9.  Molecular linkage studies of bipolar disorder.

Authors:  W H Berrettini
Journal:  Dialogues Clin Neurosci       Date:  1999-06       Impact factor: 5.986

Review 10.  Genetic bases for endophenotypes in psychiatric disorders.

Authors:  Wade H Berrettini
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.